<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000386197">
  <TermName>bendamustine hydrochloride</TermName>
  <TermPronunciation>(BEN-duh-MUS-teen HY-droh-KLOR-ide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendamustine hydrochloride damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, Bendeka, and Treanda.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000713172" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;bendamustine hydrochloride&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000713171" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de bendamustina&quot;" language="es" id="_4"/>
  <SpanishTermName>clorhidrato de bendamustina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para el tratamiento de la leucemia linfocítica crónica y ciertos tipos de linfoma no Hodgkin. También está en estudio para el tratamiento de otros tipos de cáncer. El clorhidrato de bendamustina daña el ADN de las células  y es posible que destruya células cancerosas. Es un tipo de alquilante. También se llama Belrapzo, Bendeka y Treanda.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-08-24</DateFirstPublished>
  <DateLastModified>2020-12-20</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000592692" url="/about-cancer/treatment/drugs/bendamustinehydrochloride">Bendamustine Hydrochloride</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
